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‘Public Health Laboratory, Withington Hospital, Manchester, *Public Health and Clinical 
Microbiology Laboratory, Addenbrooke’s Hospital, Cambridge, and 3Department of Microbiology, 
Lewisham Hospital NHS Trust, London, UK 
Objective: To compare four vancomycin-containing agar media for the isolation of glycopeptide-resistant enterococci 
(GRE) from clinical fecal specimens: kanamycin-aesculin-azide (KAA) agar; bile-aesculin-polymixin (BAP) agar; 
aztreonam-amphotericin blood (CBAA) agar; and neomycin blood (CBN) agar. 
Methods: Fecal specimens from 125 patients were inoculated onto each medium. Media were examined for enterococci 
after incubation for up to 48 h.  Enterococci were identified to species level, and glycopeptide phenotypes were 
determined by measuring minimum inhibitory concentrations of vancomycin and teicoplanin. 
Results: GRE were isolated from 44/125 samples. Enterococcus faecalis and Enterococcus faecium isolates, expressing 
glycopeptide resistance of the VanA or VanB phenotypes, were recovered from 27/33 (82%) specimens on BAP medium, 
26/33 (79%) on KAA medium, and 21/33 (64%) on CBN and CBAA media. Enterococcus gallinarum and Enterococcus 
casseliflavus isolates expressing low-level glycopeptide resistance (VanC phenotype) were recovered from 14/15 (93%) 
specimens on CBAA medium, 7/15 (47%) on KAA and CBN media, and 6/15 (40%) on BAP medium. 
Conclusions: The media tested in this study, with the exception of CBN medium, detected at least 75% of patients 
colonized by GRE. Further development of BAP, CBAA and KAA media is warranted to improve growth and selectivity. 
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Glycopeptide-resistant enterococci (GRE) have be- 
come established over the last 10 years as important 
nosocomial pathogens [ 11. They are increasingly 
resistant to most (if not all) available antimicrobial 
agents, and prevention of their spread has proved 
problematical, depending upon education, prudent 
antibiotic use, laboratory surveillance and infection 
control measures [2]. Several solid agar -media contain- 
ing vancomycin have been used for selective screening 
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of clinical specimens in order to identi5 colonized 
patients. Such media include colistin-nalidixic acid 
agar [3], Mueller-Hinton agar with polymyxin and 
streptomycin [4], Campylobactev agar with clindamycin 
[5], kanamycin-aesculin-azide agar [6] and Columbia 
blood agar with aztreonam and aniphotericin [7] .  As 
an alternative approach, Ford et a1 (1994) used fermen- 
tation of arabinose in a medium to select for Entevo- 
coccusfuecitrm, regardless of vancomycin resistance, as this 
species now causes the majority of nosocomial GRE 
infections [S]. In addition, ‘off-the-shelf‘ media, such 
as neomycin agar (designed for anaerobic work), have 
been adopted for the purpose 191. However, problems 
have arisen with this approach; in one study, neomycin 
agar was found to inhibit the growth of some isolates 
of E. faecium [lo]. In this comparative study, we have 
investigated the use of four agar-based, selective media 
to screen for fecal carriage of GRE. 
559 
560 C l i n i c a l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  V o l u m e  3 N u m b e r  5, O c t o b e r  1997 
METHODS 
Media 
The following media were used: kanamycin-aesculin- 
azide agar (Unipath, Basingstoke, UK) with 4 mg/L 
vancomycin (Sigma, Poole, UK)-‘KAA medium’; 
bile-aesculin agar (Unipath) with 100 mg/L poly- 
mixin B sulfate (Sigma) and 4 mg/L vancomycin-‘BAP 
medium’; Columbia agar (Unipath) with 10% horse 
blood, 4 mg/L aztreonam (Squibb, Hounslow, UK), 
2 mg/L amphotericin B (Squibb) and 4 mg/L vanco- 
mycin-‘CBAA (Lewisham) medium’; Columbia agar 
with 5% horse blood, 5 mg/L neomycin (Sigma) and 
4 mg/L vancomycin-‘CBN medium’. Media were 
prepared ‘on site’, poured as plates and stored at 4°C. 
Batches of media were used within 2 weeks of pre- 
paration and were quality controlled with a vanco- 
mycin-sensitive E. faecalis strain (NCTC 775 or ATCC 
29212) and an E. faecium isolate of the VanB phenotype. 
Clinical specimens 
A total of 125 fecal specimens was examined; 58 
were obtained from patients in four hospitals in 
Greater Manchester, and 67 were from patients at 
Addenbrooke’s Hospital, Cambridge. All specimens 
were obtained from different patients on intensive care, 
oncology or renal wards. Clinical areas were chosen 
because GRE had recently been isolated from patients 
on these wards and the prevalence of colonized patients 
was likely to be high. Specimens were collected either 
as part of routine clinical assessment (i.e. the patient 
had diarrhea) or as part of a GRE screen (eg.  routine 
screening of oncology patients). 
Bacteriologic methods 
Specimens were inoculated onto the four media either 
directly with an orange stick and streaked with a loop 
(Manchester), or with a loop following approximate 
1 in 10 dilution and emulsification in brain-heart 
infusion broth (Cambridge). Plates were incubated at 
37°C and examined for colonies with characteristics 
of enterococci at 24 and/or 48 h. Plates from all 
specimens in Cambridge and the first 50 specimens 
in Manchester were inspected at both 24 and 48 h; 
thereafter, KAA and BAP media were examined at 
48 h only and the two blood containing media were 
examined at 24 h only. One representative colony of 
each presumptive morphologic type was subcultured 
to obtain a pure culture on blood agar. Isolates were 
identified as enterococci on the basis of Gram stain, 
growth at 45°C and in 6.5% sodium chloride broth, 
hydrolysis of aesculin on bile-aesculin agar (Unipath) 
and a positive PYR test (Welcome Diagnostics, 
Dartford, UK) [ l l ] .  Speciation was performed by 
standard biochemical tests [l 1,121. Glycopeptide sus- 
ceptibilities were determined by an agar dilution MIC 
method, with vancomycin (Sigma) and teicoplanin 
(Marion Merrell Dow) pure drug powders, according 
to British Society for Antimicrobial Chemotherapy 
guidelines [13]. Glycopeptide phenotypes [14] were 
ascribed to each isolate as follows: vancomycin MIC 
28 mg/L, teicoplanin MIC 28 mg/L-VanA pheno- 
type; vancomycin MIC 28 mg/L; teicoplanin MIC 
<8 mg/L-VanB phenotype; E. casselijlavus or E. 
gallinarum with vancomycin MIC 4-16 mg/L, and 
teicoplanin MIC < 8 mg/L-VanC phenotype. 
RESULTS 
GRE were isolated from 44 of the 125 fecal samples on 
at least one medium (Table 1). Four samples contained 
two hfferent GRE (E. faecium + E.faecalis, E.faecalis + E.  
gallinarum, E. faecium + E. gallinarum, and two strains 
of E. faecium). E. faecium of the VanA phenotype were 
most commonly isolated. Enterococci with the vanB 
phenotype were found in only two specimens, and 
vancomycin-dependent enterococci were isolated from 
a single specimen. In general, ‘positive’ specimens were 
positive on two or more media, and from only a 
minority of specimens were GRE recovered on just 
one medium. E. gallinarum and E. casselijlavus (VanC 
phenotype) were cultured from nine and six specimens, 
respectively. 
Differences in positivity rates were observed among 
the media. E. faecalis and E. faecium were isolated from 
33 of the 125 specimens. E. faecalis and E. faecium 
isolates, expressing glycopeptide resistance of VanA or 
VanB phenotypes, were recovered from 27/33 (82%) 
positive specimens on BAP medium, 26/33 (79%) on 
KAA medium, and 21/33 (64%) on CBN and CBAA 
media. E. gallinarum and E. casselijlavus isolates express- 
ing low-level glycopeptide resistance (VanC pheno- 
type) were recovered from 14/15 (93%) specimens on 
CBAA medium, 7/15 (47%) on KAA and CBN media, 
and 6/15 (40%) on BAP medium. Overall, GRE (all 
phenotypes) were isolated from 35/44 (80%) positive 
samples on CBAA medium, 33/44 (75%) samples on 
BAP and KAA media and 28/44 (64%) samples on 
CBN medium. Results obtained from the two study 
centers, using different inoculation procedures, were 
comparable. These differences are not statistically 
significant at the 5% level. 
The media containing blood, CBN and CBAA 
generally enabled earlier detection of GRE than the 
two media without blood, KAA and BAP (Table 2). No 
single medium recovered all of the GRE that were 
isolated during this study. This was mainly because 
of overgrowth of coliform organisms (particularly on 
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Table 1 Glycopeptide-resistant enterococci isolated from fecal samples on different media 
Glycopeptide Number of isolates (%) recovered on indicated medium 
resistance of positive 
Organism phenotype BAP KAA CBAA CBN specimens 
Total number 
E. faecium A 24 (86) 23 (82) 20 (71) 20 (71) 28 
B 0 1 0 0 1 
Dependent 1 1 1 1 1 
E. faecalis A 2 0 0 0 2 
B 0 1 0 0 1 
Total E. faecalis 
and E. faecium 27 (82) 26 (79) 21 (64) 21 (64) 33 
E. galfinarum C 6 5 8 5 9 
E. casseliflauns C 0 2 6 2 6 
Total E. gallinarum and E. cassel$avus 6 7 14 7 15 
All GRE 33 (75) 33  (75 )  35 (80) 28 (64) 44 
CBN agar), but also due to picking of presumptive 
enterococcal colonies that were Gram-positive or 
Gram-negative bacilli. Inadequate growth of entero- 
cocci of the VanC phenotype contributed to failure to 
isolate organisms, particularly on KAA and BAP media. 
No important quantitative differences in the growth 
obtained were noted when VanA or VanB enterococci 
were recovered from a particular specimen on more 
than one medium. Organisms that were not entero- 
cocci, but which had similar colonial appearance to 
enterococci. were isolated on all media. These were 
Table 2 Time to  detection of GRE in 38 positive feces 
samples examined at 24 h and 48 h 
Medium 24 h 48 h Total 
KAA 19 8 27 
BAP 10 17 27 
CBAA 26 2 28 
CBN 20 2 22 
mainly Gram-positive bacilli, but they also included 
Gram-negative bacilli and a Pediococcus sp. Difficulties 
in distinguishing enterococci from other organisms 
were more pronounced on all media after 48 h of 
incubation, largely due to the growth of Gram-positive 
bacilli during reincubation. The characteristics of the 
media are summarized in Table 3. 
DISCUSSION 
Most media used in screening for GRE have been 
designed to detect isolates expressing high-level glyco- 
peptide resistance, predominantly of the VanA pheno- 
type. Isolates with the VanB phenotype have not 
been reported so frequently as isolates of the VanA 
phenotype [15]. This may be partly because the vanB 
gene cluster is less readily transferable between entero- 
cocci than the related V A ~  gene cluster. Nevertheless, 
recent reports indicate that VanB resistance is trans- 
ferable by conjugation in vitro [16,17] and that 
Table 3 Characteristics of selective media 
Mediuni Positive features Negative features 
HAP Aesculin-positive colonies easier to distinguish in mixtures Growth poor at 24 h, most need 48 h incubation 
Yeasts and Gram-positive bacilli not inhibited 
Gram-positive bacilli only partially inhibited 
Proteus spp. do not swarm 
Yeasts and most coliforms inhibited 
CBAA Enterococci grow well Some sensitive enterococci grow 
Proteus spp. do not swarm 
CBN Enterococci grow well 
KAA Enterococci grow well 
Yeasts, Gram-positive bacilli and some coliform organisms 
not inhibited 
Swarming of Protens spp 
Some sensitive enterococci grow 
Yeasts and Gram-positive bacilli not inhibited 
Aesculin-positive colonies easier to distinguish in mixtures 
Proteus spp. do not swarm 
Soft agar makes plating difficult 
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outbreaks of colonization and infection with VanB 
enterococci have occurred [9,18]. This type of glyco- 
peptide resistance might therefore be more of a 
problem in the future. It may also be that VanB 
enterococci are less commonly isolated because some 
strains either grow poorly in particular media [19] or 
fail to grow on agar containing the high concentrations 
of vancomycin, 20 mg/L or greater, that are commonly 
used in screening media. In this study, the vancomycin 
concentration was standardized at 4 mg/L with the 
aim of detecting enterococci of the VanB and VanC 
phenotypes as well as the VanA glycopeptide resistance 
phenotype. We have previously found a vancomycin 
concentration of 4 mg/L in agar media to give ade- 
quate recovery of laboratory VanB strains [7] (un- 
published data). 
Of the 32 glycopeptide-resistant E. fuecium or 
E. faeculis isolates recovered in our study (excluding 
the glycopeptide-dependent isolate), 30 displayed the 
VanA phenotype and only two the VanB phenotype, 
suggesting that GRE of the VanA phenotype pre- 
dominate in the hospitals involved in this study. Most 
(28/30) isolates expressing the VanA phenotype were 
E. faecium. None of the media detected all enterococci 
with Van4 or VanB resistance phenotypes. The media 
based on bile-aesculin agar P A P  and KAA) were 
most effective in the isolation of high-level-resistance 
enterococci, but had the disadvantage that growth was 
slow and incubation of cultures for 48 h was essential. 
Unfortunately, re-examination of plates at 48 h creates 
extra work and delay in the detection of GRE. 
E. casselijlavus and E. gallinarum rarely cause in- 
fections in humans, although serious infections have 
been reported [20]. Hence, depending on the circum- 
stances, it may or may not be considered an advantage 
to isolate enterococci with the VanC phenotype on 
screening media. Indeed, infection control measures 
might be implemented unnecessarily before the results 
of phenotyping or speciation become available. The 
CBAA medium was clearly superior to other media 
for the isolation of VanC enterococci. Paradoxically, 
this may have contributed to the relative reduction 
in recovery of glycopeptide-resistant E. faecium and 
E. faeculis on CBAA medium; only single (repre- 
sentative) colony picks of morphologically different 
colonies were made from the primary plates. 
Vancomycin-dependent enterococci [21-231 will 
not be isolated unless vancomycin is present in the 
primary isolation medium. Hence, the true prevalence 
of such strains is unknown. The single isolate of 
vancomycin-dependent E. faecium in our study was 
detected on all four media. Glycopeptide-dependent 
strains are likely to be reported more frequently as 
the use of screening media containing vancomycin 
becomes more widespread. While the use of a vanco- 
mycin concentration of 4 mg/L was usually effective 
in inhibiting sensitive enterococci in media without 
blood, there was some growth of vancomycin-sensitive 
enterococci on the media containing blood (approxi- 
mately 5% of specimens). A higher concentration 
(eg. 8 mg/L) might therefore be appropriate in media 
with blood, particularly when screening for high-level 
glycopeptide resistance. 
There is currently limited comparative information 
on different media that have been used to screen for 
GRE. Landman et a1 compared five different pro- 
cedures for screening perianal swabs for enterococci 
expressing high-level vancomycin resistance and found 
Enterococcosel broth containing aztreonam and vanco- 
mycin to be more sensitive than three agar media 
[24]. Van Horn et al also found Enterococcosel broth 
screening to be rapid and convenient [25]. The use of 
broth-based medla in screening for GRE clearly merits 
further evaluation, and comparison with improved 
agar-based media. We emphasize that the aim of this 
study was purely comparative: patients colonized by 
GRE could have been missed on all four media. Since 
no reliable standard method exists, it is not appropriate 
to draw definitive conclusions about the sensitivity of 
these media for the isolation of GRE. Nevertheless, 
hrther development of BAP, CBAA and KAA media 
is warranted to improve growth and selectivity, whilst 
retaining the convenience of solid media. 
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